Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 26 citing articles:

Whole-tumor radiomics analysis of T2-weighted imaging in differentiating neuroblastoma from ganglioneuroblastoma/ganglioneuroma in children: an exploratory study
Haoru Wang, Xin Chen, Wenqing Yu, et al.
Abdominal Radiology (2023) Vol. 48, Iss. 4, pp. 1372-1382
Closed Access | Times Cited: 11
High-risk neuroblastoma: ATRX and TERT as prognostic markers and therapeutic targets. Review and update on the topic
Grecia Gonzales-Céspedes, Samuel Navarro
Revista Española de Patología (2025) Vol. 58, Iss. 1, pp. 100790-100790
Closed Access
Ultrasonic-Based Radiomics Signature With Machine Learning for Differentiating Prognostic Subsets of Pediatric Peripheral Neuroblastic Tumors: A Retrospective Study
Hui Zhu, Jiazong Ye, Hongxia Luo, et al.
Ultrasound in Medicine & Biology (2025)
Open Access
Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR)
Jason A. Jarzembowski, Ian O. Ellis, Klaus Beiske, et al.
Histopathology (2025)
Open Access
Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma
Zan Liu, Zitong Zhao, Longlong Xie, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Peripheral neuroblastic tumors behaving badly: an update on high-risk morphologic and molecular groupings
Jason A. Jarzembowski, Samuel Navarro, Hiroyuki Shimada
Virchows Archiv (2025)
Closed Access
ONC201 exerts oncogenic effects beyond its mitochondria-disturbing role in neuroblastoma subsets
Jyun‐Hong Jiang, Yu-Han Lin, Pei-Lin Liao, et al.
Journal of Molecular Medicine (2025)
Open Access
Development of a Predictive Model Based on Ultrasonographic Characteristics to Distinguish Neonatal Adrenal Cystic Neuroblastoma From Hematoma
Mu-Nan Chen, Yanxiu Hu, Xiaoman Wang
Journal of Clinical Ultrasound (2025)
Closed Access
Case series on clinical applications of liquid biopsy in pediatric solid tumors: towards improved diagnostics and disease monitoring
Nina U. Gelineau, Astrid van Barneveld, Atia Samim, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Defining neuroblastoma: from origin to precision medicine
Lourdes Sainero‐Alcolado, Tomas Sjöberg Bexelius, Giuseppe Santopolo, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 12, pp. 2174-2192
Open Access | Times Cited: 2
Opportunities for interventional radiology in paediatric oncology
Fernando M. Gómez, Allison Aguado, Alex Barnacle, et al.
EJC Paediatric Oncology (2023) Vol. 3, pp. 100139-100139
Open Access | Times Cited: 4
A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients
D C Currie, Nicole Wong, Isabelle Zane, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 722-722
Open Access | Times Cited: 1
Spinal ganglioneuroma with extension to the brachial plexus. The challenges for total surgical excision, a case report
Mathias Ncheye, Peter Magembe Mrimba, Marieke C. J. Dekker, et al.
International Journal of Surgery Case Reports (2024) Vol. 119, pp. 109756-109756
Open Access | Times Cited: 1
The relationship between contrast-enhanced computed tomography radiomics features and mitosis karyorrhexis index in neuroblastoma
Xin Chen, Haoru Wang, Yuwei Xia, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Unraveling the glycosphingolipid metabolism by leveraging transcriptome-weighted network analysis on neuroblastic tumors
Arsenij Ustjanzew, Annekathrin Silvia Nedwed, Roger Sandhoff, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis
Marta Avinent-Pérez, Frank Westermann, Samuel Navarro, et al.
Neoplasia (2024) Vol. 60, pp. 101106-101106
Closed Access | Times Cited: 1
3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular in vitro bone model
Ramin Nasehi, Ali T. Abdallah, Marcella Pantile, et al.
Materials Today Bio (2023) Vol. 19, pp. 100596-100596
Open Access | Times Cited: 3
Correlations between contrast-enhanced CT-measured extracellular volume fraction, histopathological features, and MYCN amplification status in abdominal neuroblastoma: a retrospective study
Haoru Wang, Hao Ding, Mingye Xie, et al.
Abdominal Radiology (2023) Vol. 48, Iss. 11, pp. 3441-3448
Closed Access | Times Cited: 2
Epidemiological and clinical characteristics of children with peripheral neuroblastic tumors: a study on a Moroccan population
Aroua Anissi Eddaibouni, N. Bennani Guebessi, Siham Cherkaoui, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 20, pp. 18023-18027
Closed Access | Times Cited: 2
ONC201 Exerts Oncogenic Effects Beyond its Mitochondria-Disturbing Role in Neuroblastoma Subsets
Jyun‐Hong Jiang, Yu-Han Lin, Pei-Lin Liao, et al.
Research Square (Research Square) (2024)
Closed Access
Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma
Zan Liu, Zitong Zhao, Longlong Xie, et al.
Research Square (Research Square) (2024)
Closed Access
Role of Hypoxia Induced by Medicinal Plants; A Revolutionary Era of Cellular and Molecular Herbal Medicine in Neuroblastoma Treatment
Samin Rahimi, Farzana Shirin, Mahdi Moassesfar, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 12
Open Access
Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is needed
Adriana Ceci, Rosa Conte, Antonella Didio, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 1
Pan-Cancer Profiling and Digital Pathology Analysis Reveal Negative Prognostic Biomarker ZPR1 Associated with Immune Infiltration and Treatment Response in Hepatocellular Carcinoma
L He, Yusai Xie, Yusong Qiu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1309-1325
Open Access | Times Cited: 1
Analysis of High-Risk Neuroblastoma Transcriptome Reveals Gene Co-Expression Signatures and Functional Features
Mónica Martínez-Pacheco, Enrique Hernández-Lemus, Carmen Mejía
Biology (2023) Vol. 12, Iss. 9, pp. 1230-1230
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top